(Q38178774)

30 August 2017

title

Smoking cessation in patients with respiratory disease: existing treatments and future directions (English)

1 reference

30 August 2017

1 reference

1

Nancy A Rigotti

1 reference

30 August 2017

publication date

3 May 2013

1 reference

The Lancet. Respiratory medicine

30 August 2017

published in

1 reference

30 August 2017

volume

1

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

241-250

1 reference

21st-century hazards of smoking and benefits of cessation in the United States

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Addressing the growing international challenge of cancer: a multinational perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

A nationally representative case-control study of smoking and death in India

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Mortality in relation to smoking: 50 years' observations on male British doctors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Mobile phone-based interventions for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Nicotine replacement therapy for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Nicotine receptor partial agonists for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Physician advice for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Group behaviour therapy programmes for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Individual behavioural counselling for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Clonidine for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Telephone counselling for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Strategies to help a smoker who is struggling to quit

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Acupuncture and related interventions for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Hypnotherapy for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Smoking cessation strategies in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

The effectiveness of NHS smoking cessation services: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

iPhone apps for smoking cessation: a content analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Spirometry and smoking cessation advice in general practice: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Efficacy of confronting smokers with airflow limitation for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Tobacco addiction and pharmacological interventions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Clinical practice. Treatment of tobacco use and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Effectiveness of nicotine replacement therapy--a rebuttal.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Prospective determinants of smoking cessation in COPD patients within a high intensity or a brief counseling intervention

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Varenicline and bupropion sustained-release combination therapy for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Combination treatment with varenicline and nicotine replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Reduction versus abrupt cessation in smokers who want to quit

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Nicotine vaccines for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Placebo-controlled trial of cytisine for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Healthcare financing systems for increasing the use of tobacco dependence treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

Interventions for smoking cessation in hospitalised patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970063-8

7 January 2021

10.1016/S2213-2600(13)70063-8

Identifiers

DOI

1 reference

30 August 2017

1 reference